TRINCAVELLI, MARIA LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 21.032
AS - Asia 10.061
EU - Europa 8.456
SA - Sud America 1.228
AF - Africa 449
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 3
Totale 41.259
Nazione #
US - Stati Uniti d'America 20.400
IT - Italia 3.281
SG - Singapore 3.040
CN - Cina 2.801
HK - Hong Kong 1.476
SE - Svezia 1.125
VN - Vietnam 1.098
BR - Brasile 1.038
DE - Germania 825
BG - Bulgaria 653
TR - Turchia 515
CA - Canada 505
GB - Regno Unito 451
FR - Francia 415
FI - Finlandia 382
RU - Federazione Russa 307
UA - Ucraina 275
AT - Austria 247
IN - India 217
JP - Giappone 213
KR - Corea 204
CH - Svizzera 107
NG - Nigeria 98
SN - Senegal 91
CI - Costa d'Avorio 90
NL - Olanda 80
MX - Messico 71
IQ - Iraq 70
BD - Bangladesh 64
BE - Belgio 64
AR - Argentina 55
PK - Pakistan 53
PL - Polonia 50
ID - Indonesia 47
ZA - Sudafrica 47
EE - Estonia 39
ES - Italia 33
EC - Ecuador 29
IR - Iran 29
AU - Australia 28
UZ - Uzbekistan 28
VE - Venezuela 25
CO - Colombia 24
MA - Marocco 23
MY - Malesia 23
SA - Arabia Saudita 22
KE - Kenya 20
EG - Egitto 19
GR - Grecia 19
JO - Giordania 19
AE - Emirati Arabi Uniti 16
PH - Filippine 15
PY - Paraguay 15
IL - Israele 14
AZ - Azerbaigian 13
PT - Portogallo 13
UY - Uruguay 13
BJ - Benin 12
JM - Giamaica 12
NP - Nepal 12
PE - Perù 12
RO - Romania 12
CZ - Repubblica Ceca 11
LT - Lituania 11
DZ - Algeria 10
IE - Irlanda 10
TN - Tunisia 9
CR - Costa Rica 8
ET - Etiopia 8
KZ - Kazakistan 8
TW - Taiwan 8
BO - Bolivia 7
CL - Cile 7
GE - Georgia 7
TT - Trinidad e Tobago 7
AL - Albania 6
BH - Bahrain 6
PS - Palestinian Territory 6
RS - Serbia 6
KG - Kirghizistan 5
OM - Oman 5
PA - Panama 5
BF - Burkina Faso 4
BN - Brunei Darussalam 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
HN - Honduras 4
LB - Libano 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
GA - Gabon 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
KW - Kuwait 3
MD - Moldavia 3
ML - Mali 3
NI - Nicaragua 3
PR - Porto Rico 3
QA - Qatar 3
Totale 41.205
Città #
Woodbridge 2.115
Ashburn 1.967
Ann Arbor 1.899
Singapore 1.630
Houston 1.601
Hong Kong 1.447
Chandler 1.274
Fairfield 1.269
Serra 994
San Jose 987
Dallas 921
Santa Clara 888
Sofia 649
Milan 641
Shanghai 636
Beijing 590
Seattle 539
Wilmington 466
Cambridge 426
New York 426
Ottawa 410
Boardman 340
Princeton 305
Jacksonville 303
Izmir 294
Los Angeles 291
Ho Chi Minh City 251
Lawrence 244
Dong Ket 242
Lauterbourg 222
Medford 218
Hefei 208
Vienna 208
Nanjing 203
Tokyo 197
Hanoi 176
Seoul 174
Council Bluffs 173
Des Moines 172
Pisa 148
Istanbul 133
Dearborn 126
Frankfurt am Main 113
Florence 112
Helsinki 110
London 108
Buffalo 99
Lagos 96
The Dalles 94
Redondo Beach 92
Columbus 91
Dakar 91
Abidjan 90
Chicago 89
Rome 87
Munich 84
Nanchang 84
São Paulo 81
Redwood City 80
Lucca 70
Bern 68
San Diego 67
Brussels 64
Falls Church 60
Bremen 56
Lancaster 55
Kunming 54
Jüchen 48
Shenyang 48
Guangzhou 46
Da Nang 43
Ogden 43
Changsha 42
Orem 42
Rio de Janeiro 41
Turku 41
Boulder 40
Pune 40
Tianjin 40
Washington 40
Warsaw 39
Rho 38
Tallinn 38
Alessandria 36
Nuremberg 36
Phoenix 34
Amsterdam 33
Livorno 33
Hebei 31
Düsseldorf 30
Kent 30
Belo Horizonte 29
Marseille 29
Toronto 28
Auburn Hills 27
Chennai 27
Zurich 27
Fuzhou 25
Haiphong 25
Hangzhou 25
Totale 29.672
Nome #
METODO PER LA DIAGNOSI DI MALATTIE NEURODEGENERATIVE 338
G PROTEIN-COUPLED RECEPTOR DESENSITISATION REGULATES STEM CELL DIFFERENTIATION 333
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 325
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 307
Synthesis and 3D QSAR of New Pyrazolo[3,4-b]pyridines: Potent and Selective Inhibitors of A1 Adenosine Receptors 277
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 275
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 273
A (2A) ADENOSINE RECEPTOR LIGANDS AND PROINFLAMMATORY CYTOKINES INDUCE PC12 CELL DEATH THROUGH APOPTOSIS 271
Force induces axon growth in inhibitory conditions 267
New insights into the anticancer activity of carnosol: P53 reactivation in the U87MG human glioblastoma cell line 266
1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors 263
Phytochemical analysis and antisenescence activity of Sorbus torminalis (L.) Crantz and Elaeagnus umbellata Thunb fruits 262
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 254
A2A adenosine receptor binding parameters in platelets from patients affected by pathological gambling 247
Cyclic adenosine monophosphate responsive element binding protein in post-traumatic stress disorder 242
Osteogenesis Is Improved by Low Tumor Necrosis Factor Alpha Concentration through the Modulation of Gs-Coupled Receptor Signals 235
Effect of Ribes nigrum bud extract on human gingival mesenchymal stem cell cytokine release: a role on regenerative processes 233
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 232
Allosteric modulators of human A2B adenosine receptor. 231
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. 230
1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists 230
1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists 227
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 222
Carnosol controls the human glioblastoma stemness features through the epithelial-mesenchymal transition modulation and the induction of cancer stem cell apoptosis 218
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 218
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 214
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 213
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 213
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent 209
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 209
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 207
Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death 207
1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies. 205
Synthesis and AT1 affinity evaluation of benzamidophenyl analogs of known AT1 receptor ligands with similar aromatic skeleton 205
Neurotrophic Activity and Its Modulation by Zinc Ion of a Dimeric Peptide Mimicking the Brain-Derived Neurotrophic Factor N-Terminal Region 204
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 202
Epigenetic Modifications of the α-Synuclein Gene and Relative Protein Content Are Affected by Ageing and Physical Exercise in Blood from Healthy Subjects 202
1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies. 202
NEW 1,2,3-TRIAZOLO[1,5-a]QUINOXALINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS. II 200
The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization 197
A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization and down-regulation. 196
Synthesis and antihypertensive action of new Imidazo[1,2-a]pyridine derivatives, non peptidic Angiotensin II receptor antagonists 196
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 196
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 194
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 194
Negative effects of a high tumour necrosis factor-α concentration on human gingival mesenchymal stem cell trophism: The use of natural compounds as modulatory agents 194
Antioxidant activity of compounds isolated from Elaeagnus umbellata promotes human gingival fibroblast well-being 194
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 193
A1 Adenosine receptors in Human neutrophils: electron microscope localization 192
A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization and down-regulation 191
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 190
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 190
The A2B adenosine receptor modulates the epithelial- mesenchymal transition through the balance of cAMP/PKA and MAPK/ERK pathway activation in human epithelial lung cells 188
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 188
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 187
A new D2 dopamine receptor agonist allosterically modulates A2A adenosine receptor signalling by interacting with the A2A/D2 receptor heteromer 187
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 186
1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives 185
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 185
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 184
Synthesis and structure-activity relationships of a new set of 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as adenosine receptor antagonists 184
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 183
Adenosine receptors: what we know and what we are learning 180
Multimaterial and multiscale scaffold for engineering enthesis organ 179
Benzodiazepine receptos in porcine pancreatic islets 179
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 179
Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways? 179
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 179
The oral reversibly-binding antiplatelet agent, Ticagrelor, acts as an antagonist at the P2Y-like receptor GPR17 178
Livelli di citochine e cortisolo ematici in pazienti affetti da disturbo post-traumatico da stress (PTSD) e lutto complicato 176
Agonist-induced internalization and recycling of the human A(3) adenosine receptors: role in receptor desensitization and resensitization 175
A1 AND A2B ADENOSINE RECEPTORS REGULATE GLIOBLASTOMA STEM CELL DIFFERENTIATION/SURVIVAL AND SENSITIZE CELLS TO CHEMOTHERAPY 174
The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets 173
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 172
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 172
Cornus sanguinea Fruits: a Source of Antioxidant and Antisenescence Compounds Acting on Aged Human Dermal and Gingival Fibroblasts 172
Peripheral-type benzodiazepine receptor and steroid serum levels in civilian population with post-traumatic stress disorder 170
A1 adenosine receptors in human neutrophils. Electron microscope localization 168
Copper (II) ions modulate Angiogenin activity in human endothelial cells 168
A1 adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): different recognition of bovine and human binding sites 167
Allosteric modulation of A2B adenosine receptors potentiate the effects of orthosteric receptor agonists to promote mesenchymal stem cell differentiation to osteoblasts. 167
Lifetime manic-hypomanic symptoms in post-traumatic stress disorder: relationship with the 18 kDa mitochondrial translocator protein density. 166
A rapid and efficient immunoenzymatic assay to detect receptor protein interactions: g protein-coupled receptors. 166
Inflammation and neurodegeneration plasmatic biomarkers in patients with obstructive sleep apnea syndrome and mild cognitive impairment 165
Agonist-Induced Desensitization/Resensitization of Human G Protein-Coupled Receptor 17: A Functional Cross-Talk between Purinergic and Cysteinyl-Leukotriene Ligands 165
Correlation between lymphocytic peripheral benzodiazepine receptor levels and psychiatric scale scorse in post-traumatic stress disorder and traumatic grief 164
2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists 164
TUMOR NECROSIS FACTOR ALPHA TRIGGERS OSTEOGENESIS THROUGH THE INVOVLVEMENT OF Gs-COUPLED RECEPTOR SIGNALS 164
Substituted Pyrazolo3,4-bpyridines as Potent A1 Adenosine Antagonists: Synthesis, Biological Evaluation, and Development of an A1 Bovine Receptor Model 163
A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights 163
Drug Mechanism: A bioinformatic update 162
Correlations between anxiety spectrum assessments and saliva cortisol changes in post-traumatic stress disorder and traumatic grief 162
The effect of noise exposure on peripheralbenzodiazepine receptors in rat heart 161
Serotonin-mediated phosphorylation of extracellular regulated kinases in platelets of patients with panic disorder versus controls 161
Studies on enantioselectivity of chiral 4-acetylamino-6-alkyloxy-2-alkylthiopyrimidines acting as antagonists of the human A3 adenosine receptor 161
Derivatives of 4-Amino-6-hydroxy-2-mercaptopyrimidine as Novel, Potent, and Selective A3 Adenosine Receptor Antagonists 161
Extracellular adenosine oppositely regulates the purinome machinery in glioblastoma and mesenchymal stem cells 160
Modulation of PAR(1) signaling by benzimidazole compounds 159
Recettori a2a dell’adenosina in volontari sani e pazienti psicotici: differenze di genere 158
Panic-agoraphobic spectrum comorbidity and mitochondrial translocator protein in post-traumatic stress disorder 158
Totale 20.132
Categoria #
all - tutte 114.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021419 0 0 0 0 0 0 0 0 0 0 0 419
2021/20222.923 81 239 78 148 509 399 85 159 104 101 172 848
2022/20234.000 510 502 241 435 481 543 51 266 649 30 197 95
2023/20242.898 338 315 391 202 425 467 121 91 50 63 108 327
2024/20258.063 49 340 130 526 741 764 647 465 874 1.086 803 1.638
2025/20269.116 507 1.123 1.046 703 898 865 1.665 389 521 751 425 223
Totale 41.750